Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Inflammatory Bowel Disease V: Surgical Management01:21

Inflammatory Bowel Disease V: Surgical Management

760
Surgical interventions for inflammatory bowel disease (IBD), which includes ulcerative colitis and Crohn's disease, are essential in managing symptoms and addressing complications. The selection of surgical procedures is contingent upon the specific conditions and complications that stem from these illnesses.
Here are some common surgical interventions for IBD:
760
Binge Eating Disorders01:23

Binge Eating Disorders

563
Binge eating disorder is a significant mental health condition characterized by recurrent episodes of excessive food consumption within a short period, accompanied by a perceived loss of control over eating behavior. Unlike occasional overeating, binge eating disorder is marked by distressing emotions such as guilt, shame, and anxiety following binge episodes. The disorder affects individuals across different ages and backgrounds, with profound implications for physical and psychological...
563
Appendicitis-II: Diagnostic Studies and Management01:29

Appendicitis-II: Diagnostic Studies and Management

658
Diagnosing and managing appendicitis requires a structured and comprehensive approach that spans from initial assessment to postoperative care. Here is an overview of the process:
Diagnosing Appendicitis
It requires a multifaceted approach, starting with a detailed physical examination to pinpoint the location and nature of the pain and identify any associated symptoms. Laboratory tests play a crucial role. A complete Blood Count (CBC) typically reveals leukocytosis (an increased number of...
658
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution01:25

Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

322
Obesity significantly alters the pharmacokinetic processes of drug absorption and distribution, presenting unique challenges in medical treatment. The increased fat tissue and decreased lean muscle in obese individuals can significantly affect how drugs are absorbed into the body and distributed across different tissues. This alteration can lead to variances in the effectiveness and safety of medications, necessitating adjustments in dosing or drug selection for obese patients.One notable...
322
Obesity01:24

Obesity

1.4K
The Body Mass Index (BMI) is a numerical value derived from a person's weight and height, used to categorize individuals into weight ranges. It is calculated using the formula: weight in kilograms divided by height in meters squared. Obesity is a health condition characterized by excessive accumulation of adipose tissue that poses health risks, often diagnosed with a BMI ≥ 30. This excess fat storage occurs when surplus dietary calories are converted into triglycerides and stored in...
1.4K
Drug Dosing: Obese Patients01:21

Drug Dosing: Obese Patients

314
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
314

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tirzepatide: A promising treatment for obesity?

JAAPA : official journal of the American Academy of Physician Assistants·2023
See all related articles

Related Experiment Video

Updated: Feb 26, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K

Weight regain after bariatric surgery: A framework for management.

Christine G Niedbala1

  • 1Christine G. Niedbala is an associate professor of PA studies at Springfield College in Springfield, MA. The author has disclosed no potential conflicts of interest, financial or otherwise.

JAAPA : Official Journal of the American Academy of Physician Assistants
|February 24, 2026
PubMed
Summary

Postoperative weight gain affects up to 37% of patients after bariatric surgery. Early intervention with lifestyle changes and medications can help manage weight regain and improve health outcomes.

Keywords:
GLP-1 receptor agonistsbariatric surgerymetabolic surgeryobesityweight lossweight regain

More Related Videos

A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers
11:58

A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers

Published on: August 21, 2021

6.0K
Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.7K

Related Experiment Videos

Last Updated: Feb 26, 2026

Multidisciplinary Approach to Obesity Management: A Case Report
05:10

Multidisciplinary Approach to Obesity Management: A Case Report

Published on: May 30, 2025

1.3K
A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers
11:58

A Protocol for Roux-en-Y Gastric Bypass in Rats using Linear Staplers

Published on: August 21, 2021

6.0K
Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice
10:05

Techniques of Sleeve Gastrectomy and Modified Roux-en-Y Gastric Bypass in Mice

Published on: March 20, 2017

12.7K

Area of Science:

  • Metabolic and Bariatric Surgery
  • Obesity Medicine
  • Clinical Nutrition

Background:

  • Obesity is a global health crisis with rising prevalence.
  • Bariatric surgery is the most effective treatment for severe obesity, offering significant weight loss and comorbidity improvement.
  • Postoperative weight regain occurs in up to 37% of patients, negatively impacting health and quality of life.

Purpose of the Study:

  • To review the current understanding of postoperative weight regain after bariatric surgery.
  • To identify risk factors and strategies for early detection and intervention.
  • To discuss pharmacologic and surgical options for managing weight regain.

Main Methods:

  • Literature review of studies on bariatric surgery outcomes and weight regain.
  • Analysis of factors contributing to weight regain.
  • Evaluation of treatment modalities including lifestyle modifications, medications, and surgical revision.

Main Results:

  • Weight regain is associated with comorbidity recurrence and reduced quality of life.
  • Key management strategies include reinforcing lifestyle changes, mental health assessment, and frequent follow-ups.
  • Pharmacotherapies like phentermine/topiramate, GLP-1 receptor agonists (liraglutide, semaglutide), and tirzepatide are effective.
  • Surgical revision may be necessary for some patients.

Conclusions:

  • Prompt identification and intervention are crucial for managing postoperative weight regain.
  • A multimodal approach combining lifestyle, pharmacotherapy, and potentially surgical revision is recommended.
  • Further research is needed to establish formal clinical guidelines for managing weight regain post-bariatric surgery.